Senseonics to Take Over Eversense 365 Commercialization From Ascensia – RamaOnHealthcare

Senseonics to Take Over Eversense 365 Commercialization from Ascensia – RamaOnHealthcare

What You Should Know: – Senseonics Holdings, a medical technology company specializing in implantable continuous glucose monitoring (CGM) systems, has announced a Memorandum of Understanding (MOU) with Ascensia Diabetes Care to transition all global commercialization and distribution of its Eversense 365 and future products to Senseonics. Since 2020, Ascensia, a member of PHC Group, has [...]

Senseonics to Take Over Eversense 365 Commercialization from Ascensia

What You Should Know:  – Senseonics Holdings, a medical technology company specializing in implantable continuous glucose monitoring (CGM) systems, has announced a Memorandum of Understanding (MOU) with Ascensia Diabetes Care to transition all global commercialization and distribution of its Eversense 365 and future products to Senseonics. Since 2020, Ascensia, a member of PHC Group, has held the exclusive worldwide distribution rights for Evers…

Senseonics to take over commercial efforts for Eversense 365

The Eversense 365 long-term implantable CGM. [Image courtesy of Senseonics/Ascensia]Senseonics (NYSE:SENS) announced today that it entered into an agreement with Ascensia Diabetes Care to take over commercialization efforts for its products. The companies entered into a mutually executed memorandum of understanding. This agreement transitions all commercialization and distribution of the Eversense 365 long-term implantable continuous glucose mon…